Innovation & intellectual property · 25/09/2013Updated: 10/17/2026 · 1 min read
U.S. Patent Office Grants Interim Extension for Lixivaptan Patent
Summary
The U.S. Patent and Trademark Office has issued a one-year extension for the term of U.S. Patent No. 5,624,923, which covers the pharmaceutical Lixivaptan.
Original source language: Federal Register — Patent and Trademark OfficeOpen original release →